This inventor holds 1 USPTO granted patent. Top assignee: Toagosei Company, Ltd.. Active years: 1998.
Company Filing History:
Years Active: 1998
Title: Ken Hatano: Innovating Nucleic Acid Analogues in Kyoto
Introduction
Ken Hatano, a distinguished inventor based in Kyoto, Japan, has made significant strides in the field of molecular biology. His work primarily revolves around the development and synthesis of innovative nucleic acid analogues. With a strong academic background and practical expertise, he is a key player in advancing biotechnology through his inventions.
Latest Patents
Ken Hatano holds one notable patent titled "Hammerhead-like nucleic acid analogues and their synthesis." This invention presents nucleic acid compounds featuring a non-nucleic acid structure characterized by a ring skeleton. These compounds are equipped with two functional groups that maintain a fixed state, oriented in a similar direction. The patented nucleic acid compounds have the unique ability to form triple strands with third nucleotide chains, offer improved permeability, and introduce new synthetic methods to facilitate their production.
Career Highlights
Hatano's career is marked by his association with Toagosei Company, Ltd., where he contributes his expertise in research and development. His innovative contributions to nucleic acid research not only enhance scientific understanding but also hold promise for numerous applications in medicine and biotechnology.
Collaborations
Throughout his career, Ken Hatano has collaborated with notable colleagues, including Hiroshi Sugiyama and Isao Saito. These collaborations have fostered a dynamic exchange of ideas, further driving innovation within his field and enabling progress in complex scientific challenges.
Conclusion
Ken Hatano's contributions to the field of nucleic acid analogues showcase the profound impact that dedicated inventors can have on science and technology. His patented work at Toagosei Company, Ltd. represents a significant advancement in molecular biology, paving the way for future innovations that could transform therapeutic approaches and enhance our understanding of genetic materials. Through collaboration and continued research, Hatano remains a pivotal figure in the evolving landscape of biotechnology.